Clinical trial

Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)

NCT00093015

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-08-01

PhasePHASE3

Study timeline

Study start (actual)2004-08-01Date precision: day

Registry last updated2022-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Kidney Diseaseunresolved

Diabetes Mellitusunresolved

Anemiaunresolved

Interventions

PlaceboDRUG

darbepoetin alfaDRUG · verified · RxNorm: darbepoetin alfa

Sponsors & collaborators

Amgenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00093015 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.